These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Antiviral drug discovery and development: where chemistry meets with biomedicine. De Clercq E Antiviral Res; 2005 Aug; 67(2):56-75. PubMed ID: 16046240 [TBL] [Abstract][Full Text] [Related]
44. [Multiple sclerosis and herpetic infection]. Kruhliak HO Lik Sprava; 2004; (1):3-8. PubMed ID: 17051701 [TBL] [Abstract][Full Text] [Related]
45. Herpes virus infections, HIV, and disease progression. Wait and see. Japour A AIDS Clin Care; 1995 Feb; 7(2):15, 18. PubMed ID: 12212540 [No Abstract] [Full Text] [Related]
46. Acyclic nucleoside phosphonates: a key class of antiviral drugs. De Clercq E; Holý A Nat Rev Drug Discov; 2005 Nov; 4(11):928-40. PubMed ID: 16264436 [TBL] [Abstract][Full Text] [Related]
47. [Comments on the contribution by M. Vogt et al. New developments and prospects in antiviral chemotherapy]. Rieckemann B; Ranneberg B Internist (Berl); 1993 Feb; 34(2):190. PubMed ID: 8384189 [No Abstract] [Full Text] [Related]
48. Nature of the antiviral activity of statolon. Prince HN; Grunberg E Antimicrob Agents Chemother (Bethesda); 1965; 5():588-92. PubMed ID: 4286924 [No Abstract] [Full Text] [Related]
60. Natural Products and Their Derivatives against Human Herpesvirus Infection. Ruchawapol C; Yuan M; Wang SM; Fu WW; Xu HX Molecules; 2021 Oct; 26(20):. PubMed ID: 34684870 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]